Abstract:Since the 2013 Nobel Prize was awarded for the discovery of vesicle trafficking, a subgroup of nanovesicles called exosomes has been driving the research field to a new regime for understanding cellular communication. This exosome-dominated traffic control system has increased understanding of many diseases, including cancer metastasis, diabetes, and HIV. In addition to the important diagnostic role, exosomes are particularly attractive for drug delivery, due to their distinctive properties in cellular information transfer and uptake. Compared to viral and non-viral synthetic systems, the natural, cell-derived exosomes exhibit intrinsic payload and bioavailability. Most importantly, exosomes easily cross biological barriers, obstacles that continue to challenge other drug delivery nanoparticle systems. Recent emerging studies have shown numerous critical roles of exosomes in many biological barriers, including the blood–brain barrier (BBB), blood–cerebrospinal fluid barrier (BCSFB), blood–lymph barrier (BlyB), blood–air barrier (BAB), stromal barrier (SB), blood–labyrinth barrier (BLaB), blood–retinal barrier (BRB), and placental barrier (PB), which opens exciting new possibilities for using exosomes as the delivery platform. However, the systematic reviews summarizing such discoveries are still limited. This review covers state-of-the-art exosome research on crossing several important biological barriers with a focus on the current, accepted models used to explain the mechanisms of barrier crossing, including tight junctions. The potential to design and engineer exosomes to enhance delivery efficacy, leading to future applications in precision medicine and immunotherapy, is discussed.

Harnessing Exosomes for the Development of Brain Drug Delivery Systems

Engineered Exosomes: A Promising Drug Delivery Strategy for Brain Diseases

Exosomes As CNS Drug Delivery Tools and Their Applications

Emerging prospects of extracellular vesicles for brain disease theranostics

Exosomes as a Nanodelivery System: a Key to the Future of Neuromedicine?

Exosome-based drug delivery systems for enhanced neurological therapeutics

Cell-derived nanovesicle-mediated drug delivery to the brain: Principles and strategies for vesicle engineering

Bioengineering Extracellular Vesicles As Novel Nanocarriers Towards Brain Disorders

Exosomes: A Cellular Communication Medium That Has Multiple Effects On Brain Diseases

Strategies for Targeted Delivery of Exosomes to the Brain: Advantages and Challenges

Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies

Exosomes as therapeutic and drug delivery vehicle for neurodegenerative diseases

Navigating the brain: the role of exosomal shuttles in precision therapeutics

Extracellular vesicles: biological mechanisms and emerging therapeutic opportunities in neurodegenerative diseases

The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System

Unlocking the Power of Exosomes for Crossing Biological Barriers in Drug Delivery

Targeted Drug Delivery to the Central Nervous System Using Extracellular Vesicles

Engineering exosomes as refined biological nanoplatforms for drug delivery

Nature's carriers: leveraging extracellular vesicles for targeted drug delivery

Harnessing exosomes for targeted therapy: strategy and application